Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health

The document argues that Resorcinol should be identified as a substance of very high concern (SVHC) under REACH article 57(f) because it is an endocrine disruptor that inhibits thyroperoxidase (TPO), affecting thyroid hormone levels. The authors highlight severe developmental risks for unborn children, including hypothyroidism and neurological impacts, and note that the substance is a high-volume compound used in cosmetics, pharmaceuticals, and rubber products. They contend that the substance meets the 'equivalent level of concern' (ELoC) criteria and that failure to identify it would undermine the EU Chemicals Strategy for Sustainability.

• Resorcinol is identified as an endocrine disruptor that inhibits thyroperoxidase (TPO), an enzyme essential for thyroid hormone synthesis, which can lead to severe developmental effects in humans such as hypothyroidism, goiter, and neurological impacts in children.
• The substance is a high-volume compound with annual registrations between 1,000 and 10,000 tons, used in various consumer and industrial applications including cosmetics, hygiene products, pharmaceuticals, flame retardants, adhesives, resins, and rubber products.
• The authors argue that Resorcinol meets the 'equivalent level of concern' (ELoC) criteria under REACH article 57(f) because its effects on prenatal brain development are severe, long-term, and irreversible.
• A previous attempt to identify Resorcinol as an SVHC at the ECHA Member State Committee 70 in June 2020 failed because Member States could not reach unanimity regarding the equivalent level of concern (ELoC) criteria.

APA

ClientEarth (2021). Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health. https://www.clientearth.org/media/ioipoeza/resorc_3.pdf

Chicago

ClientEarth. Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health. 2021. https://www.clientearth.org/media/ioipoeza/resorc_3.pdf.

Wikipedia

{{cite press release |author=ClientEarth |title=Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health |date=6 September 2021 |url=https://www.clientearth.org/media/ioipoeza/resorc_3.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@misc{clientearth2021resorcinol, author = {{ClientEarth}}, title = {{Resorcinol vote at the REACH Committee meeting of 22-23 September: support the adequate SVHC identification of this known endocrine disruptor for health}}, publisher = {ClientEarth}, year = {2021}, month = sep, url = {https://www.clientearth.org/media/ioipoeza/resorc_3.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }